Q3 2015 Holdings
Filed 2015-11-13 | 77 holdings | $325.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biogen Inc(BIIB) | COMMON | 09062X103 | $182.4M | 625,096 | 56.1% |
| Biomarin Pharmaceutical Inc(BMRN) | COMMON | 09061G101 | $102.1M | 969,823 | 31.4% |
| Align Tech Inc(ALGN) | COMMON | 016255101 | $29.1M | 512,393 | 8.9% |
| Acadia Healthcare(ACHC) | COMMON | 00404A109 | $8.5M | 128,054 | 2.6% |
| Ascendis Pharma A S(ASND) | SP ADR | 04351P101 | $550.0K | 31,100 | 0.2% |
| Amphastar Pharmaceuticals(AMPH) | COMMON | 03209R103 | $489.0K | 41,800 | 0.2% |
| Coherus Biosciences(CHRS) | COMMON | 19249H103 | $331.0K | 16,498 | 0.1% |
| Gilead Sciences Inc(GILD) | COMMON | 375558103 | $182.3K | 1,856,458 | 0.1% |
| Celgene Corp(CELG) | COMMON | 151020104 | $137.1K | 1,267,158 | 0.0% |
| Regeneron Pharmaceuticals(REGN) | COMMON | 75886F107 | $113.5K | 244,100 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COMMON | 015351109 | $112.9K | 721,593 | 0.0% |
| Incyte Corporation(INCY) | COMMON | 45337C102 | $97.9K | 887,051 | 0.0% |
| Amicus Therapeutics(FOLD) | COMMON | 03152W109 | $85.5K | 6,111,227 | 0.0% |
| Amgen Inc(AMGN) | COMMON | 031162100 | $76.7K | 554,697 | 0.0% |
| Vertex Pharmaceuticals(VRTX) | COMMON | 92532F100 | $76.5K | 734,200 | 0.0% |
| Thermo Fisher Scientific(TMO) | COMMON | 883556102 | $74.1K | 605,636 | 0.0% |
| Merck & Co Inc(MRK) | COMMON | 58933Y105 | $54.2K | 1,097,376 | 0.0% |
| Pfizer Inc(PFE) | COMMON | 717081103 | $53.7K | 1,711,016 | 0.0% |
| Seattle Genetics Inc | COMMON | 812578102 | $48.9K | 1,269,075 | 0.0% |
| Portola Pharmaceuticals | COMMON | 737010108 | $46.4K | 1,088,118 | 0.0% |
| Allergan PLC | SHARES | G0177J108 | $38.6K | 142,009 | 0.0% |
| Intercept Pharmaceuticals(ICPTUSD) | COMMON | 45845P108 | $36.4K | 219,647 | 0.0% |
| Halozyme Therapeutic(HALO) | COMMON | 40637H109 | $35.9K | 2,671,051 | 0.0% |
| Medtronic PLC(MDT) | SHARES | G5960L103 | $35.2K | 525,952 | 0.0% |
| Teva Pharmaceutical(TEVA) | ADR | 881624209 | $33.6K | 594,950 | 0.0% |
| Dexcom Inc(DXCM) | COMMON | 252131107 | $27.8K | 323,233 | 0.0% |
| Shire PLC | SP ADR | 82481R106 | $25.1K | 122,056 | 0.0% |
| Alder Biopharmaceuticals(ALDR1EUR) | COMMON | 014339105 | $25.0K | 762,682 | 0.0% |
| United Therapeutics(UTHR) | COMMON | 91307C102 | $23.1K | 175,780 | 0.0% |
| ST Jude Medical Inc | COMMON | 790849103 | $22.4K | 354,911 | 0.0% |
| Unitedhealth GRP Inc(UNH) | COMMON | 91324P102 | $22.2K | 191,148 | 0.0% |
| Edwards Lifescience(EW) | COMMON | 28176E108 | $21.8K | 153,115 | 0.0% |
| Aimmune Therapeutics(AIMT) | COMMON | 00900T107 | $20.1K | 792,638 | 0.0% |
| PTC Therapeutics Inc(PTCT) | COMMON | 69366J200 | $18.4K | 690,364 | 0.0% |
| Chimerix Inc(CMRXEUR) | COMMON | 16934W106 | $18.2K | 476,500 | 0.0% |
| Pronai Therapeutics | COMMON | 74346L101 | $17.3K | 862,766 | 0.0% |
| Mylan N V | SHS EURO | N59465109 | $16.8K | 417,082 | 0.0% |
| DR Reddys Labs LTD(RDY) | ADR | 256135203 | $16.3K | 254,901 | 0.0% |
| Relypsa Inc | COMMON | 759531106 | $15.6K | 842,030 | 0.0% |
| Uniqure N.V.(QURE) | SHARES | N90064101 | $15.6K | 761,913 | 0.0% |
| Acceleron Pharma(XLRN) | COMMON | 00434H108 | $15.2K | 612,184 | 0.0% |
| TG Therapeutics(TGTX) | COMMON | 88322Q108 | $14.8K | 1,464,105 | 0.0% |
| Cara Therapeutics(CARAEUR) | COMMON | 140755109 | $14.6K | 1,023,309 | 0.0% |
| Novartis AG(NVSN) | SP ADR | 66987V109 | $13.4K | 145,305 | 0.0% |
| Advaxis Inc | COMMON | 007624208 | $12.9K | 1,263,415 | 0.0% |
| Novo-Nordisk AS(NVO) | ADR | 670100205 | $12.8K | 235,375 | 0.0% |
| Heartware Intl Inc | COMMON | 422368100 | $11.7K | 224,580 | 0.0% |
| Nxstage Medical | COMMON | 67072V103 | $11.2K | 712,329 | 0.0% |
| Intuitive Surgical Inc(ISRG) | COMMON | 46120E602 | $11.1K | 24,096 | 0.0% |
| Regenxbio Inc(RGNX) | COMMON | 75901B107 | $10.8K | 507,441 | 0.0% |